Author:
Ailawadhi Sikander,Chanan-Khan Asher
Reference31 articles.
1. Chu E, DeVita VC. Physician's cancer chemotherapy drug manual. Sudbury, MA: Jones and Bartlett; 2006.
2. Robert J. Anthracyclines. In: A clinician's guide to chemotherapy pharmacokinet-ics and pharmacodynamics. Vol. 93 (3rd edition). Baltimore, MD: Williams 8 Wilkins; 1983.
3. Sharpe M, Easthope SE, Keating GM, et al. Polyethylene-glycol-liposomal doxoru-bicin: A review of its use in the management of solid and hematological malignancies and AIDS-related kaposi's sarcoma. Drugs. 2002;62:2089–2126.
4. Gabizon AA. Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 2001;19:424–436.
5. Hussein MA, Wood L, Hsi E, et al. A phase II trial of pegylated liposomal doxo-rubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients. Cancer. 2002;95:2160–2168.